Skip to main content

RxNews®

Valuable and timely information on drug therapy issues impacting today's health care and pharmacy environment.

Veozah® (fezolinetant) – Boxed warning added

December 16, 2024 - The FDA approved a label update to Astellas’ Veozah (fezolinetant), adding a Boxed Warning for the risk of hepatotoxicity.

Download PDF

Rx navigation